21 /100
LOW RISK
Score updated May 30, 2026

FDMT — 4D Molecular Therapeutics, Inc. Dilution Risk Tracker

Track FDMT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FDMT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FDMT.
🔔 Track FDMT — Get forecast alerts →

💹 Market Data

Market Cap$518.06M
Shares Outstanding52.28M
Float38.84M
Cash$390.89M
Debt$20.54M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.2% shares (2025Q4 vs prior)
154 institutional holders · 54.63M shares
#1 RA CAPITAL MANAGEMENT, L.P. 5.65M shares
#2 JANUS HENDERSON GROUP PLC 4.64M shares
#3 BVF INC/IL 4.63M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.08M
Days to Cover19.1
% of Float31.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track FDMT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FDMT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for FDMT
📊 FDMT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FDMT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.